Kidney Cancer

Votrient 400 mg is widely prescribed by doctors for treating advanced renal cell carcinoma (kidney cancer). The medicine belongs to a class of drugs known as tyrosine kinase inhibitors (TKI). Widely indicated for treating patients suffering from advanced renal cell carcinoma (RCC), it is also useful in patients with advanced soft tissue sarcoma (STS) who have previously received chemotherapy.

Sorafenib Tosylate Tablets are widely used in the treatment of thyroid cancer, liver cancer and advanced renal cell carcinoma, a type of kidney cancer. Indicated in the treatment of hepatocellular carcinoma, this medicine is also prescribed for patients with advanced renal cell carcinoma who previously has failed interferon-alpha or interleukin-2 based therapy. The medication is also highly effective against progressive, locally advanced or metastatic, differentiated thyroid carcinoma. It is basically a cancer medication, works effectively by interfering with the spread and growth of cancer cells in the body.

Sorafenib 200 mg Tablets are widely used in the treatment of thyroid cancer, liver cancer and advanced renal cell carcinoma, a type of kidney cancer. The medication is highly effective against progressive, locally advanced or metastatic, differentiated thyroid carcinoma. In addition, it is also indicated for treating hepatocellular carcinoma and prescribed for patients with advanced renal cell carcinoma who previously has failed interferon-alpha or interleukin-2 based therapy. The medicine is basically a cancer medication which interferes with the spread and growth of cancer cells in the body.